Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mortality in rheumatoid disease.

William R Finch1

  • 1Education and Research Service, Carl T. Hayden VA Medical Center, Phoenix, AZ 85012, USA. William.Finch@med.va.gov

Journal of Insurance Medicine (New York, N.Y.)
|October 22, 2004
PubMed
Summary

Rheumatoid disease significantly increases mortality, primarily due to cardiovascular deaths linked to shared inflammatory mechanisms. Managing inflammation and cardiovascular risks is crucial for improving outcomes in rheumatoid disease patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Creating Evidence-Based Ratings and Life Expectancies Medical Impairments.

Journal of insurance medicine (New York, N.Y.)·2026
Same journal

The Smoking Dilemma: A Technical Deep Dive.

Journal of insurance medicine (New York, N.Y.)·2026
Same journal

Biological Clocks: Ready for Prime Time?

Journal of insurance medicine (New York, N.Y.)·2026
Same journal

GLP-1 Therapies and Mortality Risk: Implications for Life Insurers.

Journal of insurance medicine (New York, N.Y.)·2026
Same journal

Identifying Benzodiazepine Abuse: A Report of 3 Cases.

Journal of insurance medicine (New York, N.Y.)·2026
Same journal

Between Fear and Adoption: The AI Paradox in Medico-Legal Practice Among National Insurance Physicians.

Journal of insurance medicine (New York, N.Y.)·2026

Area of Science:

  • Rheumatology
  • Cardiovascular Medicine
  • Inflammation Biology

Background:

  • Rheumatoid disease is often underestimated, potentially due to the term "rheumatoid arthritis."
  • Significant excess mortality is well-established in patients with rheumatoid disease.
  • Cardiovascular disease deaths are a major contributor to this excess mortality.

Purpose of the Study:

  • To provide an overview of rheumatoid disease, emphasizing its impact on mortality.
  • To highlight the shared biologic mechanisms between rheumatoid disease and cardiovascular disease.
  • To discuss factors influencing mortality risk and potential therapeutic strategies.

Main Methods:

  • Review of numerous long-term studies and established literature.
  • Analysis of associations between disease severity, functional decline, inflammatory activity, and mortality risk.
  • Discussion of the role of inflammatory biomarkers and cardiovascular risk factor management.

Main Results:

  • Rheumatoid disease is associated with significant excess mortality, predominantly from cardiovascular causes.
  • Shared inflammatory pathways link rheumatoid and cardiovascular diseases.
  • Extraarticular disease severity, functional decline, and inflammatory activity correlate with increased mortality risk.

Conclusions:

  • Effective management of rheumatoid disease requires addressing cardiovascular risks due to shared inflammatory mechanisms.
  • Novel inflammatory biomarkers may aid in prognosis and therapy monitoring.
  • Further research is needed to determine if disease-modifying antirheumatic drug (DMARD) therapy impacts all-cause and cardiovascular mortality.

Related Experiment Videos